Reneuron Share Discussion Threads

[jensonbensonjohnson] 25/10/2019 13:55

I tend to agree with you for once, Mr Chung. Well, I think 50p's probably pushing it a bit but I reckon it'll drop in to double-figures.

[ken chung] 25/10/2019 13:41

50p coming.Enjoy the drop.Lemmings and mushrooms only.

[hashertu] 24/10/2019 22:44

Michael Hunt confirmed that Blackrock have the Woodford shareholding, not Park Hill.
Shame.

[supernumerary] 24/10/2019 12:39

Patient Capital is to be run by Schroders, and has seen a surge in its share price as a result. It looks as though that fund at least will have some time to recover values.

[dickbush] 24/10/2019 12:02

Thanks, big23. That was very helpful to me re the possible timing of any sale. Unfortunately, it isn't very helpful for RENE who must be continuing to burn through their cash.

It's a really frustrating situation for the company and us. I think the shares could be flying without this overhang.

[hashertu] 23/10/2019 14:36

BG23. I suspect that RENE comes under the "unlisted and hard-to-sell listed assets" heading, the sale of which comes the control of Park Hill. Not that that will make much difference to us. Nor the date that dealing will/should start.

[investordave] 23/10/2019 10:44

It certainly seems that way.

[stewart_25] 23/10/2019 10:16

What news and yet not much share price movement... market doesn't like RENE for sure!!!

[dickbush] 23/10/2019 09:55

bg23 If you were looking to acquire wouldn't you want to make a couple of phone calls asap to pick up 33% at a knock-down price from enthusiastic sellers?

IMO, if we didn't have the Woodford holding overhanging, with this announcement the company would be getting back to concept status with the share price passing through recent highs.

[bg23] 23/10/2019 09:22

exciting news.... but little reaction.

still, further confirms my interest and investment in this minnow.

re woodford. its likely his/links shareholdings are tied up until January when blackrock come in to liquidate. Sure, sales may be lined up ahead of time, but that in itself is likely to engender a degree of uncertainty amongst interested commercial partners who might be interested in either working with or acquiring an interest in Reneuron.

[investordave] 23/10/2019 08:24

Despite good news I see the weekly shop sellers are now out again.

[dickbush] 23/10/2019 08:21

This must increase RENE'S attractions either for Fosun-style deals or as an acquisition.

Maybe this will stir some institutions to take out Woodford's shares. That's what I want to see.

[ayl30] 23/10/2019 08:20

Has been for a while but nothing yet!

[bonzo] 23/10/2019 08:19

Immortality no, but the ability to treat a huge range of diseases using a patented platform technology -yes...

[bantam175] 23/10/2019 08:13

This has to be a take out target for someone like Glaxo/Roche/Bayer etc before the Chinese snap it up.

[rayrac] 23/10/2019 08:06

Is it in auction?

[ayl30] 23/10/2019 07:32

Good news and progress, let's see how the share price reacts today

[bantam175] 23/10/2019 07:23

Oh wow, amazing news. Did RENE just invent immortality ;-)

What's that worth?

[rrb] 18/10/2019 11:41

there are trading desks that could buy this stake. It is tiny and I fully expect there will be plenty of buyers, at these depressed levels.

[jensonbensonjohnson] 18/10/2019 09:40

Note to self: read RNS's properly in future. I thought Woodford had managed to sell 16% of RENE to someone.

Mind you, it's holding up OK today. Nothing has really changed, I suppose.

[dickbush] 18/10/2019 09:35

This was always an out-and-out speculation for me, although I was fairly happy with the company's progress, particularly the RP trials. This just adds another layer of uncertainty.

[hashertu] 18/10/2019 09:04

Have a read of Rambutan post 98, Arix thread.
Note time line.
Also, my own experience of a fund wind-down (up?) is that the tail end sales can be quite extended in time.